EMCURE PHARMACEUTICALS
Back to All Ratios
|
EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 10.02 | 8.82 | 7.77 | 9.21 | 11.75 |
What is the latest Profit After Tax (PAT) Margin ratio of EMCURE PHARMACEUTICALS ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2026 | 10.02 |
| Mar2025 | 8.82 |
| Mar2024 | 7.77 |
| Mar2023 | 9.21 |
| Mar2022 | 11.75 |
How is Profit After Tax (PAT) Margin of EMCURE PHARMACEUTICALS Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2026 | 10.02 | 13.61 | |
| Mar2025 | 8.82 | 13.51 | |
| Mar2024 | 7.77 | -15.64 | |
| Mar2023 | 9.21 | -21.62 | |
| Mar2022 | 11.75 | - | |
Other Financial Ratios of EMCURE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,118.2 Cr | -4.8% | -3.9% | 46.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -4.8% |
-3.9% |
46.8% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses